iHealth COVID-19 Antigen Rapid Test (Single box 2 Test)

Have Insurance? Call or Text Your Insurance Card to see if the test(s) are covered. 

469.596.0341

FDA Authorized, non-invasive, and easy to use, the iHealth COVID-19 Antigen Home Rapid Self-Test is an effective antigen test, used for home use or point-of-care testing, to determine active covid-19 infection in a patient. An individual with or without symptoms, may it be a 2-year-old child or a full-grown adult, can easily be tested and get accurate results in just 15 minutes.

Simple and Efficient: This COVID-19 Antigen Rapid Test was made by iHealth to quickly detect Sars-CoV-2 nucleocapsid protein antigen in a person, following only 4 simple steps of testing. Using the included highly-absorbent nasal swab, the specimen can be obtained by brushing 5 times against the inner wall of both nostrils of a patient. You can effectively get a sample just by inserting 1/2 to 3/4-inch of the swab inside the nose since this test kit promotes optimal comfort for the user.

The specimen is then mixed with the solution inside the tube, thoroughly mixing 15 times to make sure that all the samples collected are incorporated with the buffer solution. Simply put 3 drops of the solution in the sample well of the kit’s COVID-19 test card, and wait for 15 minutes. Fast and precise results can help individuals and healthcare professionals be aware of the situation, which can greatly help in proper diagnosis and action.

Quick & Accurate Result: Results will automatically appear on the stick after a few minutes, and you can determine its meaning based on the result reference guide in the kit. A solo horizontal mark on the "C" (control) area depicts that you have a negative result. A positive result shows two marks for the "C" and "T" (test) zones. Invalid results show no lines on the stick or incomplete lines.

FDA Disclaimer: This swab test kit is not FDA cleared or approved, but only authorized under an Emergency Use Authorization for home use or point of care use. It is authorized for the rapid detection of proteins from SARS-CoV-2 and not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for the detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

     FDA emergency use authorized